Prescription drug · ANDA
Granisetron Hydrochloride NDC 51991-735
Granisetron hydrochloride 1 mg/1 · Tablet · Oral · Breckenridge Pharmaceutical, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51991-735-20 | 5199107352051991073520 | 2 BLISTER PACK in 1 CARTON (51991-735-20) / 10 TABLET in 1 BLISTER PACKMarketed from Jun 22, 2009 | |
| 51991-735-32 | 5199107353251991073532 | 1 BLISTER PACK in 1 CARTON (51991-735-32) / 2 TABLET in 1 BLISTER PACKMarketed from Jun 22, 2009 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Granisetron Hydrochloride
- Generic name (nonproprietary)
- granisetron hydrochloride
- Active ingredients
- Granisetron hydrochloride — 1 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Breckenridge Pharmaceutical, Inc.NDC labeler code 51991
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078969
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin 3 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 51991-735_1919cca7-47e5-4474-8ad1-a49275d4f85bSPL ID 1919cca7-47e5-4474-8ad1-a49275d4f85bSPL set ID df4b6775-4337-41e0-815a-b064d98c3fe1RxCUI 310599UNII 318F6L70J8UPC 0351991735328
- Pharmacologic class
- Serotonin-3 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451991073520followed by a unit qualifier and the quantityPackage 51991-0735-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Granisetron hydrochloride tablets USP are indicated for the prevention of: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.
Excerpt only. Read the full label for complete information.
About NDC 51991-735
- What is NDC 51991-735?
- 51991-735 is the product NDC for Granisetron Hydrochloride, Granisetron hydrochloride 1 mg/1 tablet, listed with the FDA by Breckenridge Pharmaceutical, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Granisetron Hydrochloride.
- What is the active ingredient?
- Granisetron hydrochloride.
- Who is the labeler?
- Breckenridge Pharmaceutical, Inc., NDC labeler code 51991. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Granisetron Hydrochloride?
- 9 other product NDCs are listed under this name. See all Granisetron Hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Granisetron Hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Granisetron Hydrochloride | Granisetron hydrochloride 1 mg/1 | Tablet, Film coatedOral | Bionpharma Inc. | 69452-350 | 69452-0350-0169452-0350-1169452-0350-92 |
| Granisetron Hydrochloride | Granisetron hydrochloride .1 mg/mL | Injection, SolutionIntravenous | Mylan Institutional LLC | 67457-861 | — |
| Granisetron Hydrochloride | Granisetron hydrochloride 1 mg/mL | Injection, SolutionIntravenous | Mylan Institutional LLC | 67457-863 | 67457-0863-01 |
| Granisetron Hydrochloride | Granisetron hydrochloride 1 mg/mL | Injection, SolutionIntravenous | Mylan Institutional LLC | 67457-864 | 67457-0864-04 |
| Granisetron Hydrochloride | Granisetron hydrochloride 1 mg/mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-175 | 55150-0175-01 |
| Granisetron Hydrochloride | Granisetron hydrochloride 4 mg/4mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-176 | 55150-0176-04 |
| Granisetron Hydrochloride | Granisetron hydrochloride 1 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9744 | 00143-9744-10 |
| Granisetron Hydrochloride | Granisetron hydrochloride 1 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9745 | 00143-9745-0500143-9745-10 |
| Granisetron hydrochloride | Granisetron hydrochloride 1 mg/1 | Tablet, Film coatedOral | Natco Pharma Limited | 63850-0005 | 63850-0005-0163850-0005-02 |
Other NDCs under ANDA 078969
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Granisetron hydrochloride | Granisetron hydrochloride 1 mg/1 | Tablet, Film coatedOral | Natco Pharma Limited | 63850-0005 |